Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dowdy

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
AIDS Patient Care and Stds|May 7, 2011
Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency departmentKaterina A Christopoulos, Beth Kaplan, David Dowdy, et al.
Journal of the International AIDS Society|June 21, 2020
Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspectiveParastu Kasaie, Brian Weir, Melissa Schnure, et al.
Scientific Reports|July 30, 2016
Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov modelMark W Moses, Alice Zwerling, Adithya Cattamanchi, et al.
Journal of the American College of Cardiology|May 19, 2012
Sudden cardiac death in patients with human immunodeficiency virus infectionZian H Tseng, Eric A Secemsky, David Dowdy, et al.
BMJ Global Health|March 29, 2022
Cost-effectiveness analysis of human-centred design for global health interventions: a quantitative frameworkChen Liu, Jae Hyoung Lee, Amanda J Gupta, et al.
Plos One|December 31, 2015
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South AfricaGwenan M Knight, Gabriela B Gomez, Peter J Dodd, et al.
Plos One|February 4, 2021
Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in UgandaRachel K Lim, Fred C Semitala, Elly Atuhumuza, et al.
BMC Pulmonary Medicine|October 5, 2022
A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populationsJames Mahon, Sophie Beale, Hayden Holmes, et al.
BMC Public Health|July 3, 2026
Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South AfricaRachel Mukora, Resignation Pelusa, Noriah Maraba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2022
Model-based Analysis of Tuberculosis Genotype Clusters in the United States Reveals High Degree of Heterogeneity in Transmission and State-level Differences Across California, Florida, New York, and TexasSourya Shrestha, Kathryn Winglee, Andrew N Hill, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
AIDS Patient Care and Stds|May 7, 2011
Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency departmentKaterina A Christopoulos, Beth Kaplan, David Dowdy, et al.
Journal of the International AIDS Society|June 21, 2020
Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspectiveParastu Kasaie, Brian Weir, Melissa Schnure, et al.
Scientific Reports|July 30, 2016
Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov modelMark W Moses, Alice Zwerling, Adithya Cattamanchi, et al.
Journal of the American College of Cardiology|May 19, 2012
Sudden cardiac death in patients with human immunodeficiency virus infectionZian H Tseng, Eric A Secemsky, David Dowdy, et al.
BMJ Global Health|March 29, 2022
Cost-effectiveness analysis of human-centred design for global health interventions: a quantitative frameworkChen Liu, Jae Hyoung Lee, Amanda J Gupta, et al.
Plos One|December 31, 2015
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South AfricaGwenan M Knight, Gabriela B Gomez, Peter J Dodd, et al.
Plos One|February 4, 2021
Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in UgandaRachel K Lim, Fred C Semitala, Elly Atuhumuza, et al.
BMC Pulmonary Medicine|October 5, 2022
A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populationsJames Mahon, Sophie Beale, Hayden Holmes, et al.
BMC Public Health|July 3, 2026
Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South AfricaRachel Mukora, Resignation Pelusa, Noriah Maraba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2022
Model-based Analysis of Tuberculosis Genotype Clusters in the United States Reveals High Degree of Heterogeneity in Transmission and State-level Differences Across California, Florida, New York, and TexasSourya Shrestha, Kathryn Winglee, Andrew N Hill, et al.
Pageof 11